It is far too easy to alter and dismiss scientific findings because of political pressure. US policy continues to struggle with the integration of scientific integrity within national issues. A dedication to accurate reporting of findings, along with a promise of policy guided by science, is crucial to repairing a flawed system. At the Science [...]
Even in the 21st century, women are consistently underrepresented in clinical trials involving drug therapy, medical devices, and behavioral interventions. Although various US federal agencies have made improvements to legislation regarding women’s participation in clinical trials over the past few decades, recent studies demonstrate that the underrepresentation of women remains a persistent problem that raises [...]
While undeniable strides in medical research over the past few decades have proven invaluable in the search for a cancer cure, there is no shortage of obstacles that remain to be addressed. Perhaps the most evident are complications in the biology of the disease itself: among these, problems pertaining to cell identification and treatment specificity. [...]
The road to HIV/AIDS prevention and treatment is an arduous one. Vaccine research and trials have been plagued with failures.[i] Culture and poverty in highly affected areas have left education programs fruitless. The marginal position of women, especially in Sub-Saharan Africa, has left them practically defenseless against infection by their often more promiscuous male partners, [...]
The general public may question the wisdom of investing so much time and money into efforts that may never provide practical returns. This is the reason that in this year’s budget, the 17.68 billion dollar question is: why conduct science for the sake of science?